Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

The new HLA allele HLA-C*05:199 was detected and characterized in a Spanish family.

Download full-text PDF

Source
http://dx.doi.org/10.1111/tan.13467DOI Listing

Publication Analysis

Top Keywords

hla-c*05199 generated
4
generated intralocus
4
intralocus recombination
4
recombination involving
4
involving c*05010101
4
c*05010101 c*16010101
4
c*16010101 alleles
4
alleles hla
4
hla allele
4
allele hla-c*05199
4

Similar Publications

Aim: To explore the potential axiological shift in nursing, drawing upon a critical reading of the new definition of 'nursing' published by the International Council of Nurses (ICN) in June 2025, and to articulate its implications for research and doctoral education.

Design: Critical discussion paper.

Methods: Guided by critical inquiry and emancipatory nursing knowledge development approaches, this paper deploys retroductive analysis to interrogate the axiological commitments that inform and are generated by the 2025 ICN definition and how it relates to nursing research.

View Article and Find Full Text PDF

Aim: To explore the identity and body experiences of emerging adults with congenital heart disease.

Design: Qualitative descriptive study.

Methods: Narratives from 152 emerging adults about living with congenital heart disease and its impact on their identity and body experiences were analysed using template analysis.

View Article and Find Full Text PDF

Background: Gait impairment in Parkinson's disease (PD) occurs early and pharmaceutical interventions do not fully restore this function. Visual cueing has been shown to improve gait and alleviate freezing of gait (FOG) in PD. Technological development of digital laser shoe visual cues now allows for visual cues to be used continuously when walking.

View Article and Find Full Text PDF

Objective: To evaluate the clinical characteristics, social deprivation, insurance coverage, and medication use across regional subsets of patients with psoriatic arthritis (PsA) in the US.

Methods: A cross-sectional study of PsA patients in the Rheumatology Informatics System for Effectiveness (RISE) registry between January 2020 and March2023 was conducted. Distribution of high disease activity (HDA - RAPID3>12), high comorbidity (RxRisk ≥90 percentile), high Area Deprivation Index (ADI ≥80), insurance coverage, prednisone ≥10mg daily, and all DMARD therapies across geographic regions were evaluated.

View Article and Find Full Text PDF